Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,445
Closed -$177K 10094
2025
Q1
$177K Buy
+14,445
New +$221K ﹤0.01% 8536
2023
Q3
Sell
-18,723
Closed -$369K 8900
2023
Q2
$369K Buy
+18,723
New +$294K ﹤0.01% 6801
2022
Q3
Sell
-31,864
Closed -$286K 9961
2022
Q2
$286K Buy
31,864
+11,507
+57% +$134K ﹤0.01% 7680
2022
Q1
$360K Buy
20,357
+8,889
+78% +$277K ﹤0.01% 8078
2021
Q4
$652K Sell
11,468
-5,400
-32% -$360K ﹤0.01% 6767
2021
Q3
$1.27M Buy
16,868
+15,241
+937% +$1.61M ﹤0.01% 5424
2021
Q2
$273K Buy
+1,627
New +$285K ﹤0.01% 8315

Other funds holding GOCO

Jane Street's GOCO Position: Q2 2025 in Review

Jane Street sold out of GoHealth (GOCO) in Q2 2025, closing a stake of 14,445 shares — an estimated $177K sold.

Jane Street first reported a position in GOCO in Q2 2021 and held it in 7 quarters. The position peaked at $1.27M in Q3 2021. 55 funds tracked by Wall St. Rank hold GOCO as of Q2 2025.

  • Jane Street reported no remaining GoHealth position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 14,445 GoHealth shares in Q2 2025, an estimated $177K.
  • Jane Street first reported a position in GoHealth in Q2 2021 and held it in 7 quarters.
  • Jane Street's GoHealth position peaked at $1.27M in Q3 2021.
  • 55 funds tracked by Wall St. Rank held GoHealth as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.